VECT
VectivBio Holding AGNASDAQHEALTHCAREPHARMACEUTICALS
Key Statistics
Market Cap
$1.06B
P/E Ratio
—
EPS
$-2.10
Beta
0.10
52W High
$0.00
52W Low
$0.00
50-Day MA
$15.86
200-Day MA
$10.35
Dividend Yield
0.00%
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
0.00
About VectivBio Holding AG
VectivBio Holding AG, a clinical-stage biopharmaceutical company, focuses on the discovery, development and commercialization of treatments for rare conditions. The company is headquartered in Basel, Switzerland.
Fundamentals
| Revenue (TTM) | $27.34M |
| Gross Profit (TTM) | $27.34M |
| EBITDA | $-80.42M |
| Operating Margin | -294.50% |
| Return on Equity | -56.90% |
| Return on Assets | -25.90% |
| Revenue/Share (TTM) | $0.62 |
| Book Value | $3.40 |
| Price-to-Book | 3.62 |
| Price-to-Sales (TTM) | 21.08 |
| EV/Revenue | 14.37 |
| EV/EBITDA | -5.21 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $62.81M |
| Float | $31.09M |
| % Insiders | 4.50% |
| % Institutions | 83.80% |
Historical Volatility
HV 10-Day
0.00%
HV 20-Day
0.00%
HV 30-Day
0.00%
HV 60-Day
0.00%
HV Rank
100.0%
Volatility is currently contracting
Data last updated: 4/14/2026